Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
BMC Neurology|July 8, 2022
Perioperative levetiracetam for seizure prophylaxis in seizure-naive brain tumor patients with focus on neurocognitive functioningElias Konrath, Franz Marhold, Wolfgang Kindler, et al.
Brain & Spine|November 29, 2023
European survey on neurosurgical management of primary central nervous system lymphomas and preoperative corticosteroid therapyFlorian Scheichel, Branko Popadic, Daniel Pinggera, et al.
Anesthesia and Analgesia|August 31, 2004
Closed suctioning system reduces cross-contamination between bronchial system and gastric juicesWerner Rabitsch, Wolfgang J Köstler, Wolfgang Fiebiger, et al.
Anesthesia and Analgesia|August 31, 2004
Inhibition of platelet function by hydroxyethyl starch solutions in chronic pain patients undergoing peridural anesthesiaWerner Rabitsch, Wolfgang J Köstler, Wolfgang Fiebiger, et al.
Experimental Neurology|March 24, 2015
The secretome of apoptotic human peripheral blood mononuclear cells attenuates secondary damage following spinal cord injury in ratsThomas Haider, Romana Höftberger, Beate Rüger, et al.
Cancers|February 5, 2021
Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System LymphomaJulia Furtner, Karl-Heinz Nenning, Thomas Roetzer, et al.
Cancers|June 21, 2020
Sex-Specific Differences in Primary CNS LymphomaThomas Roetzer, Julia Furtner, Johanna Gesperger, et al.
Neurosurgery|June 12, 2024
Open Microsurgical Cerebral Aneurysm Treatment After Failed Endovascular Therapy: An Evaluation of Aneurysm Treatment Frequencies in All Neurovascular Centers Across Austria and the Czech Republic Over 20 YearsChristoph J Griessenauer, Philippe Dodier, Nico H Stroh, et al.
Neuro-Oncology Advances|November 29, 2023
Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphomaKarl-Heinz Nenning, Johanna Gesperger, Julia Furtner, et al.
Nature Medicine|August 29, 2018
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and spaceJohanna Klughammer, Barbara Kiesel, Thomas Roetzer, et al.
Pageof 6